Completed
Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
NCT02151786
- Conditions
- Digestive System Diseases, Duodenal Diseases, Duodenal Ulcer, +6 more
- Locations
-
Not specified